CLINICAL_TRIALS
trial_result
· 2017-12-15
Clinical Trial Update: Adding Liraglutide to High Dose Insulin: Breaking the Cycle [Phase 4]
Summary
Phase 4 trial evaluating adding liraglutide to high-dose insulin in patients with type 2 diabetes mellitus and obesity; results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ildiko Lingvay | Conditions: Type 2 Diabetes Mellitus, Obesity | Phase 4 | Status: COMPLETED | Results posted: 2017-12-15